2024
Implementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing?
Afranie-Sakyi J, Karimi M, Bozzo J, Cole J, Van Doren L, Calhoun C. Implementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing? Blood 2024, 144: 5009-5009. DOI: 10.1182/blood-2024-201816.Peer-Reviewed Original ResearchYale New Haven Health SystemHistory of strokeCognitive screeningGuideline publicationHealth systemSilent cerebral infarctionCognitive disordersImplementation ratePredictors of screeningSickle cell diseaseRates of screeningMood disordersAmerican Society of HematologyPrevalence of cognitive disordersDetect silent cerebral infarctsDevelopment of interventionsCognitive impairmentManual chart reviewICD-10 diagnosisEmergency room visitsDiagnosis of sickle cell diseaseSickle Cell CenterAmerican Society of Hematology guidelinesOutpatient encountersMRI screening
2016
Higher Prevalence of Hydroxyurea Use Is Associated with Lower Hospitalization Rate in a Population of Children with Sickle Cell Disease
Calhoun C, Colvin R, Verlekar A, Lassa-Claxton S, Cole F, Hulbert M. Higher Prevalence of Hydroxyurea Use Is Associated with Lower Hospitalization Rate in a Population of Children with Sickle Cell Disease. Blood 2016, 128: 315. DOI: 10.1182/blood.v128.22.315.315.Peer-Reviewed Original ResearchSt. Louis Children's HospitalSickle cell diseaseLower hospitalization ratesHematopoietic stem cell transplantPopulation of childrenStem cell transplantHospitalization ratesSevere genotypeCell diseaseGenotype groupsHydroxyurea useTotal hospitalizationsCell transplantOutpatient encountersVaso-occlusive pain episodesHU treatmentStudy periodImpact of hydroxyureaMore outpatient encountersReduced hospitalization ratesHigher hospitalization ratesRate of hospitalizationICD-9 codesUnrelated medical conditionsGenotypes of SCD